CTIX Stock | News | Quote | Stock Forum | Monday, December 16,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 16, 2013 at 1:41 AM

$CTIX Cellceutix Corp. CTIX Company Overview

Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.84
Previous Close 1.82 Open 1.85
Daily Range 1.87 - 1.80 52wk Range 2.47 - 1.39
Volume 141,387 Dividend N/A
Average Vol (3m) 200,056 Yield N/A

CTIX Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!

Last Updated: Monday, December 16, 2013 01:41:42 AM

Cellceutix Corp. CTIX
Company Information

100 Cumming Center
Suite 151-B
Beverly, MA 01915

Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com

Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Cellceutix Corp. CTIX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts

Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors

Not Available
Company Notes

Formerly=EconoShare, Inc. until 2-2008
Service Providers

Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States

Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC

Cellceutix Corp. CTIX
CTIX Security Details

Share Structure

Market Value1 $193,041,843 a/o Dec 13, 2013
Shares Outstanding 104,914,045 a/o Nov 04, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value 0.0001
Shareholders

Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data

Short Interest 126,239 (51.54%)
Nov 29, 2013
Significant Failures to Deliver No
Transfer Agent(s)

West Coast Stock Transfer Inc.

Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations

Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)

Cellceutix Corp. CTIX Recent News

Dec 9, 2013 Cellceutix Updates on Current Status of Programs
Nov 18, 2013 Cellceutix Identifies Drug Candidates for Gram-Negative and Candida Fungal Infections
Nov 12, 2013 News and Updates on CTIX, CERP, NVIV and TRTC
Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)

1
2
next >

CTIX Cellceutix Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Targets Coastal Financial Over Missteps

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

BRIJ Medical Secures $5M: Paving Path for Product Launches

In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...

Zayne Burgess Accelerates Towards Formula 1 with K1 Speed

A Young Racer's Roaring Start Every once in a while, a kid shows up on the scene who just makes you sit up and pay attention. Enter Zayne Burgess, a mere 10-year-old with the skill set of a seasoned pro. If you care about the future of racing, you better start watching this young'un, because he's chasing a Formula 1 dream and has K1 Speed putting their chips on him....

Kia's Thunderous October Sales Surge: What's Under the Hood?

Electric Pulse: Kia's Electrified Dreams Soar No one said the road to the top is easy, yet Kia America is cruising along with six straight months of shattering sales records. October's monumental figures paint the picture clear as a bell — 80,008 units dispatched to eager drivers, with electrified and hybrid models zooming to new heights. It ain't just the same old...

Tarte's Record-Breaking Collab: 60 Seconds to Sellout

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Artprice Bridges Art and AI Across the Hispanic World

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Baidu Faces Fraud Allegations: What Investors Should Know

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

HikTech Star Tour Highlights Co-Innovation at Hikvision

Innovation Meets Collaboration at HikTech Star Tour Ever been to one of those tech expos that's more about hype than substance? No smoke and mirrors here. The 2026 HikTech Star Tour wasn’t your run-of-the-mill tech meet-up. Held in Hangzhou, the event brought together 130 tech professionals from 56 countries. It’s like a digital United Nations, but with fewer speeches...

Telemed Sites Need Solid Payment Systems with AI

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...